NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.77
+0.45 (3.65%)
Apr 14, 2026, 4:00 PM EDT - Market closed
NextCure Market Cap
NextCure has a market cap or net worth of $45.47 million as of April 15, 2026. Its market cap has increased by 225.33% in one year.
Market Cap
45.47M
Enterprise Value
8.80M
1-Year Change
225.33%
Ranking
Category
Stock Price
$12.77
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $45.47M, a decrease of -89.58%. That is a compound annual growth rate of -27.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 45.47M | -8.60% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 47.07M |
| Cue Biopharma | 46.13M |
| RenovoRx | 45.95M |
| Atossa Therapeutics | 45.73M |
| Lisata Therapeutics | 45.07M |
| Telomir Pharmaceuticals | 44.70M |
| Werewolf Therapeutics | 44.59M |
| Rallybio | 43.90M |